We are live on ! Find out more
RCP

Rothschild Capital Partners Portfolio holdings

AUM $408M
1-Year Est. Return 25.87%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+25.87%
3 Year Est. Return
+81.82%
5 Year Est. Return
+111.3%
10 Year Est. Return
+529.64%
AUM
$232M
AUM Growth
+$8.04M
Cap. Flow
-$626K
Cap. Flow %
-0.27%
Top 10 Hldgs %
52.2%
Holding
52
New
11
Increased
12
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
CSII
Cardiovascular Systems, Inc.
CSII
+$6.58M
2
EPC icon
Edgewell Personal Care
EPC
+$5.68M
3
CTXS
Citrix Systems Inc
CTXS
+$5.6M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$4.78M
5
HEDJ icon
WisdomTree Europe Hedged Equity Fund
HEDJ
+$3.97M

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$12.8M
2
STWD icon
Starwood Property Trust
STWD
+$6.82M
3
TMO icon
Thermo Fisher Scientific
TMO
+$5.44M
4
DXCM icon
DexCom
DXCM
+$5.02M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.25M

Sector Composition

Rank Sector Weight
1 Healthcare 20.17%
2 Technology 19.66%
3 Communication Services 11.92%
4 Energy 7.18%
5 Industrials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPI
51
DELISTED
UROPLASTY INC-NEW
UPI
– –
-599,131
Closed -$731K
1 2
3

Similar funds

CIM
Coleford Investment Management Toronto, Ontario, Canada $408M AUM 25.62% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
QCI
Quaker Capital Investments Mount Lebanon, Pennsylvania $409M AUM 61.78% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
PCP
Perbak Capital Partners London, United Kingdom $406M AUM 17.25% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
LPC
Lineage Point Capital Palm Beach, Florida $409M AUM
KM
KP Management Edina, Minnesota $409M AUM 68.3% 1-Year Est. Return

Rothschild Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Rothschild Capital Partners held 52 positions worth $232M, up 3.6% from $224M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Rothschild Capital Partners's Q2 2015 filing shows 11 new, 12 increased, 16 reduced and 6 closed positions. Its largest new stake was Cardiovascular Systems, Inc.: 203,715 shares worth $5.39M. The largest sale was Insulet, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.

  • Rothschild Capital Partners's largest Q2 2015 buy was Cardiovascular Systems, Inc.: 203,715 shares worth $5.39M.
  • Rothschild Capital Partners added most to State Street SPDR S&P Regional Banking ETF in Q2 2015, an estimated $4.78M increase.
  • Rothschild Capital Partners's biggest Q2 2015 reduction was Thermo Fisher Scientific, cutting an estimated $5.44M.
  • Rothschild Capital Partners fully exited Insulet in Q2 2015, selling an estimated $12.8M.
  • Rothschild Capital Partners's ten largest holdings make up 52% of its $232M portfolio in Q2 2015.
  • Rothschild Capital Partners opened 11 new positions and closed 6 in Q2 2015.
  • Rothschild Capital Partners's portfolio value rose 3.6% quarter-over-quarter to $232M.

Based on Rothschild Capital Partners's 13F filing for Q2 2015, filed 31 Jul 2015.